| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 35.66B | 33.53B | 36.84B | 33.45B | 30.51B |
| Gross Profit | 11.07B | 10.82B | 9.93B | 10.96B | 10.28B | 9.10B |
| EBITDA | 6.93B | 6.76B | 6.31B | 6.60B | 6.09B | 5.09B |
| Net Income | 4.08B | 3.87B | 3.33B | 4.08B | 3.47B | 2.76B |
Balance Sheet | ||||||
| Total Assets | 59.05B | 59.80B | 59.45B | 56.67B | 54.81B | 53.27B |
| Cash, Cash Equivalents and Short-Term Investments | 12.45B | 14.30B | 12.86B | 8.94B | 12.86B | 14.37B |
| Total Debt | 17.21M | 1.10B | 27.65M | 35.66M | 16.32M | 15.01M |
| Total Liabilities | 9.80B | 10.73B | 11.89B | 10.57B | 10.25B | 10.42B |
| Stockholders Equity | 48.35B | 48.16B | 46.65B | 45.27B | 43.73B | 42.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.75B | 5.01B | -1.32B | -542.08M | 1.96B |
| Operating Cash Flow | 0.00 | 4.09B | 6.28B | 1.44B | 2.29B | 4.70B |
| Investing Cash Flow | 0.00 | -1.77B | -634.16M | -1.78B | -2.74B | -2.42B |
| Financing Cash Flow | 0.00 | -602.16M | -2.55B | -3.32B | -1.40B | -874.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥63.28B | 13.85 | ― | 2.96% | 3.03% | 28.27% | |
77 Outperform | ¥85.73B | 17.11 | 10.57% | 1.80% | 15.12% | 40.72% | |
72 Outperform | ¥53.06B | 17.14 | 6.31% | 4.03% | 6.38% | 22.81% | |
69 Neutral | ¥48.87B | 8.46 | 10.88% | 4.52% | -1.14% | 34.15% | |
67 Neutral | ¥58.27B | 12.94 | ― | 2.82% | 8.28% | 0.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥59.11B | 30.77 | ― | 1.65% | 1.20% | ― |
Nippon Fine Chemical Co., Ltd. announced the retirement of 1,550,000 common shares, representing 6.1% of issued shares, as part of a strategic move to optimize its capital structure. This decision, effective November 20, 2025, is expected to enhance shareholder value and reflects the company’s proactive approach to managing its financial resources.
Nippon Fine Chemical Co., Ltd. has revised its earnings forecast for the fiscal year ending March 2026, citing better-than-expected results in the second quarter. The company anticipates increases in net sales, operating profit, and profit attributable to owners, reflecting strong performance in its beauty care, healthcare, and fine chemicals segments.
Nippon Fine Chemical Co., Ltd. reported a modest increase in net sales for the first half of 2025, with significant growth in operating and ordinary profits, reflecting improved operational efficiency. The company has revised its earnings forecast for the fiscal year ending March 31, 2026, indicating a positive outlook despite a slight decrease in expected net sales, which suggests a strategic focus on profitability and shareholder value.
Nippon Fine Chemical Co., Ltd. has updated its management strategies to better align with the cost of capital and stock price considerations. This initiative, discussed in a recent Board of Directors meeting, aims to address current challenges and improve operational efficiency, potentially impacting the company’s market positioning and stakeholder relations.